Well said virtual, the reverence 'institutions' are held in by many retail investors is astonishing and perplexing. CardioCel and the ADAPT technologies are game changers and Professor Frazer's DNA technology could also be a game changer therefore it's highly plausible that over the next decade AHZ could come to dominate the twin fields of regenerative medicine and DNA vaccines. This, in my opinion, is what investors should be concentrating on, not whether the opaque MC whoever is buying or selling.
curious, page-8
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.91 |
Change
-0.090(0.50%) |
Mkt cap ! $344.2M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.75 | $74.32K | 4.151K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 681 | $17.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.25 | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |